Carey RM, Fathy R, Shah RR, Rajasekaran K, Cannady SB, Newman JG, Ibrahim SA, Brant JA.
2020.
Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.. JAMA Netw Open. 3(1):e1919697.
Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D et al..
2020.
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.. J Am Heart Assoc. 9(4):e013606.
Wirrell EC, Grinspan ZM, Knupp KG, Jiang Y, Hammeed B, Mytinger JR, Patel AD, Nabbout R, Specchio N, J Cross H et al..
2020.
Care Delivery for Children With Epilepsy During the COVID-19 Pandemic: An International Survey of Clinicians.. J Child Neurol. :883073820940189.
Dinh CT, Linn KA, Isidro U, Emanuel EJ, Volpp KG, Bond AM, Caldarella K, Troxel AB, Zhu J, Yang L et al..
2020.
Changes in Outpatient Imaging Utilization and Spending Under a New Population-Based Primary Care Payment Model.. J Am Coll Radiol. 17(1 Pt B):101-109.
Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Nelson BBaltich, Askin G, Christos PJ, Holcomb K, Caputo TA et al..
2020.
Clinicopathologic features of endometrial cancer with mismatch repair deficiency.. Ecancermedicalscience. 14:1061.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.